When PepsiCo acquired Poppi for nearly $2 billion in early 2025, everyone assumed Olipop would be next. Rumors swirled, negotiations stalled with Coca-Cola, and then...Olipop walked away. Critics claimed they missed the peak of the prebiotic soda mania. But the truth could be much more rebellious. In this video, I break down why Olipop's independence isn't a failure, analyze Olipop's impressive financial health ($700M+ in tracked sales), and explore three hidden paths for unlocking their future enterprise value.

In this video, you’ll learn more about:

• Olipop "Mistiming Myth": Why critics are wrong about Olipop missing the prebiotic trend.
• Red Bull & Monster Energy Factor: How alternative distributors could change the convenience store game.
• Gut Health M&A Roll-Up Strategy: How Olipop could clone the Simply Good Foods playbook to target an IPO in 12-18 months.
• Food Tech Pivot: Transforming OliSmart into a B2B ingredient supplier.

What do you think? Should Olipop sell to Coke, or should they build an independent gut-health empire?